Parkinson’s Disease Therapy Study
PARKINSON’S DISEASE THERAPY STUDY
We are seeking individuals with Parkinson’s Disease for a study investigating the impact of multimodal non-invasive neuromodulation and intensive physical therapy on balance.
What the study will include
This study will compare the effectiveness of a 2-week intervention of physical therapy alone to physical therapy + neurostimulation on balance in individuals with Parkinson’s Disease.
Neurostimulation includes two different non-invasive devices:
- The first is the Portable Neuromodulation Stimulator (PoNS™). The use of the PoNS™ device in this study is investigational. Brain stimulation via the PoNS™ device stimulates two cranial nerves connected to the tongue, and is thought to aid in neuroplasticity.
- Galvanic Vestibular Stimulation (GVS) delivers a mild electrical current to the vestibular nerves located directly underneath the skin behind your ears. Similar to PoNS™ stimulation, GVS is thought to aid in neuroplasticity.
The use of the PoNS™ and GVS devices in this study is investigational.
Participants will have continued access to their unique PoNS™ device after study completion.
You may qualify as a study participant if:
- You have a diagnosis of idiopathic Parkinson’s Disease
- Approximately 4-weeks including:
- Screening and baseline visit
- Two 90min sessions per day
- 5 days per week for 2 weeks
The study requires you to participate in-person at the Surrey Neuroplasticity Clinic (located at Unit 1004, City Centre 3, 13761 96 Ave., Surrey, BC, V3V 0E8).
More study information:
Site Principal Investigator (Study Doctor):
Dr. Ryan C.N. D’Arcy, Ph.D., PIEng, Neuroscience
President and Chief Scientific Officer, HealthTech Connex
BC Leadership Chair, Neurotechnology and Neuroimaging
Professor, Computer Science and Engineering Science
Simon Fraser University
Professor, DM Centre for Brain Health, Department of Radiology, University of British Columbia
Dr. Martin McKeown, MD, FRCPC, Neurology
Professor, Department of Neurology, Faculty of Medicine, University of British Columbia
Director, Pacific Parkinson’s Research Centre
PPRI/UBC Chair in Parkinson’s Research